Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? - results of a randomized, double-blind, placebo-controlled clinical trial

By Yang X.J.   Lecksell K.   Short K.   Gottesman J.   Peterson L.   Bannow J.   Schellhammer P.F.   Fitch W.P.   Hodge G.B.   Parra R.   Rouse S.   Waldstreicher J.   Epstein J.I.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 696-700

Elsevier

Access to resources Recommend Favorite

Study of the Association between Ischemic Heart Disease and Use of Alpha-Blockers and Finasteride Indicated for the Treatment of Benign Prostatic Hyperplasia

By Souverein P.C.   Herings R.M.C.   Man in 't Veld A.J.   de la Rosette J.J.M.C.H.   Farmer R.D.T.   Leufkens H.G.M.  

European Urology, Vol. 42, Iss. 3, 2002-09 ,pp. : 254-261

Elsevier

Access to resources Recommend Favorite

Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up

By Miller M.I.   Puchner P.J.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 237-240

Elsevier

Access to resources Recommend Favorite

Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia

By Roehrborn C.G.   Lee M.   Meehan A.   Waldstreicher J.   PLESS STUDY GROUP  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 894-899

Elsevier

Access to resources Recommend Favorite

Effects of finasteride and cyproterone acetate on hematuria associated with benign prostatic hyperplasia: a prospective, randomized, controlled study

By Perimenis P.   Gyftopoulos K.   Markou S.   Barbalias G.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 373-377

Elsevier

Access to resources Recommend Favorite